[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100618661":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":31,"centralContacts":36,"locations":46,"responsibleParty":63,"collaborators":26,"id":67,"slug":26,"hasResults":68,"nctId":69,"briefTitle":70,"officialTitle":71,"acronym":26,"eligibilityCriteria":72,"healthyVolunteers":68,"sex":73,"minAge":74,"maxAge":75,"enrollmentInfo":76,"targetDuration":26,"studyType":79,"phases":80,"briefSummary":82,"conditions":83,"keywords":26,"overallStatus":85,"whyStopped":26,"lastUpdateSubmitDate":86,"lastUpdatePostDateStruct":87,"startDateStruct":90,"completionDateStruct":92,"leadSponsor":94,"locationsCount":95},{"fullName":5,"class":6},"Karbala University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Virtual Reality Group","EXPERIMENTAL","Participants in this group will receive distraction therapy using Virtual Reality (VR) glasses during the AVF insertion. The VR session starts 2 minutes before the procedure and continues for 3 minutes during the insertion. Utilizing the Solomon Four-Group Design, this group is randomly subdivided into two subgroups: in Subgroup A, anxiety is assessed before the intervention, while in Subgroup B, no pre-test assessment is performed. Both subgroups undergo post-test measurement for pain and anxiety immediately after the procedure.",[13],"Device: Virtual Reality",{"label":15,"type":16,"description":17,"interventionNames":18},"Control Group","ACTIVE_COMPARATOR","Participants in this group will receive standard routine nursing care for AVF insertion without any additional distraction techniques. Utilizing the Solomon Four-Group Design, this group is randomly subdivided into two subgroups: in Subgroup C, anxiety is assessed before the procedure, while in Subgroup D, no pre-test assessment is performed. Both subgroups undergo post-test measurement for pain and anxiety immediately after the procedure",[19],"Other: standard of care",[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"DEVICE","Virtual Reality","The intervention involves using VR glasses to provide audiovisual distraction. Participants will watch a 360-degree underwater video with calming music. The VR session starts 2 minutes before the procedure and continues for 3 minutes during the insertion",[9],null,{"type":6,"name":28,"description":29,"armGroupLabels":30,"otherNames":26},"standard of care","Routine nursing care for AVF insertion, including skin disinfection and needle insertion according to the hospital's standard protocols, without any additional distraction techniques.",[15],[32],{"name":33,"affiliation":34,"role":35},"Astabraq R Hussein, MGS","kerbala heath department","PRINCIPAL_INVESTIGATOR",[37,42],{"name":38,"role":39,"phone":40,"phoneExt":26,"email":41},"Astabraq R Hussien, MGS","CONTACT","+9647718107352","astabraq.r@s.uokerbala.edu.iq",{"name":43,"role":39,"phone":44,"phoneExt":26,"email":45},"Hassan A Athbi, Assoc. Prof","+9647721902514","hasan.abdallh@uokerbala.edu.iq",[47,58],{"facility":48,"status":26,"city":49,"state":26,"zip":26,"country":50,"countryCode":51,"cosmosGeoPoint":52,"geoPoint":57,"contacts":26},"Imam Al-Hassan Al-Mujtaba Teaching Hospital","Karbala","Iraq","IQ",{"type":53,"coordinates":54},"Point",[55,56],44.02488,32.61603,{"lat":56,"lon":55},{"facility":59,"status":26,"city":49,"state":26,"zip":26,"country":50,"countryCode":51,"cosmosGeoPoint":60,"geoPoint":62,"contacts":26},"Imam Al-Hussain Teaching Hospital",{"type":53,"coordinates":61},[55,56],{"lat":56,"lon":55},{"type":35,"investigatorFullName":64,"investigatorTitle":65,"investigatorAffiliation":66,"oldNameTitle":26,"oldOrganization":26},"Astabraq Rassoul Hussein Abass","Graduate Researcher","Ministry of Health, Iraq","100618661",false,"NCT07334522","Virtual Reality Distraction for Pain and Anxiety in Hemodialysis Patients","Effect of Distraction Technique Using Virtual Reality on Pain and Anxiety Level During Needle Insertion in Arteriovenous Fistula Among Hemodialysis Patients: A Randomized Controlled Trial","Inclusion Criteria:\n\n* Adult patients with End-Stage Renal Disease (ESRD) on hemodialysis.\n* Patients using a functioning arteriovenous fistula (AVF).\n* Conscious, oriented, and able to communicate.\n* Normal or corrected vision and hearing suitable for VR use.\n* Patients capable of giving written informed consent.\n\nExclusion Criteria:\n\n* History of motion sickness, seizures, or epilepsy.\n* Use of Central Venous Catheter (CVC) or Arteriovenous Graft (AVG).\n* Use of analgesics or sedatives within 4 hours before the procedure.\n* Facial wounds or eye infections preventing VR use.\n* Hemodynamic instability or cognitive impairment.","ALL","18 Years","70 Years",{"count":77,"type":78},150,"ESTIMATED","INTERVENTIONAL",[81],"NA","1. Assess pain and anxiety levels in hemodialysis patients during arteriovenous fistula needle insertion.\n2. Determine the effect of the distraction technique using virtual reality on pain and anxiety levels during arteriovenous fistula needle insertion in hemodialysis patients.\n3. Find out the differences in the level of pain and anxiety after using virtual reality with regard to the demographic and clinical data of the sample.",[84],"Pain Management","NOT_YET_RECRUITING","2026-01-09",{"date":88,"type":89},"2026-01-13","ACTUAL",{"date":91,"type":78},"2025-12-25",{"date":93,"type":78},"2026-06-20",{"name":5,"class":6},2]